Arata Corporation · TSE:2733
Arata — Q1 FY03/2025 Earnings Presentation
12 slides from Arata's earnings presentation, August 2024
Slide 1: ARATA Corporation Q1 FY03/2025 Financial Results
NOTICE The slides in this presentation has been translated using a mechanical automatic translation service. In some cases, the translation may be inaccurate or unintended. Please use this service with the understanding that translations are not always accurate. ARATA Corporation Q1 of Fiscal Year E
Slide 2: Q1 of FY03/2025 Highlights
Q1 of FY03/2025 results ■ Q1 of FY03/2025 Highlights Market Environment Due to the depreciation of the yen Inbound travel Due to the 2024 issue of Logistics and the rise in crude oil prices Increase in opportunities to go out and labor shortage Increase in the flow of people Soaring utility costs Ri
Slide 3: Consolidated Statements of Income
Q1 of FY03/2025 results ■ Consolidated Statements of Income Q1 of Q1 of Progress FY03/2024 FY03/2025 YoY change rate Planning (Millions of JPY) Results Results Change Rate (%) Rate (%) Net sales 235,239 245,604 10,364 104.4 969,000 25.3 Gross profit 23,221 24,726 1,505 106.5 - - SG&A expenses 18,873
Slide 4: Record high net sales
Q1 of FY03/2025 results ■ Q1 of FY03/2025 factors Record high net sales Net Sales : JPY245.604 billion YoY: +JPY10.364 billion 104.4% Q1 of FY03/2025 Cumulative Net Sales YoY 104.4% Increased for 10 consecutive years Implementation of category strategies in response to environmental changes Expand s
Slide 5: Record high Ordinary income
Q1 of FY03/2025 results ■ Q1 of FY03/2025 factors Record high Ordinary income Ordinary income: JPY5.057 billion YoY: +JPY388 million 108.3% Gross profit : JPY24.726 billion YoY: +JPY1.505 billion 106.5% Gross margin: 10.07% YoY +0.20 points +Factors: Strong sales of exclusive cosmetics (strong sales
Slide 6: Sales by Category (YoY)
Q1 of FY03/2025 results ■ Sales by Category (YoY) Health & Beauty (Millions of JPY) 80,000 74,352 71,216 Percentage of Net Sales Q1 of FY03/2024 30.3% Q1 of FY03/2025 60,000 104.4% 45,474 45,373 42,883 44,189 40,000 35,481 32,946 104.2% 106.0% 102.7% 24,725 23,719 98.3% 20,000 107.7% 15,112 14,859 1
Slide 7: Sales by Business Category (YoY)
Q1 of FY03/2025 results ■ Sales by Business Category (YoY) (Millions of JPY) 140,000 127,772 122,801 Q1 of FY03/2024 Drugstores 120,000 Percentage of Net Sales Q1 of FY03/2025 100,000 52.0% 104.0% 80,000 60,000 105.9% 34,041 36,058 103.2% 104.9% 40,000 27,079 108.3% 26,155 26,228 18,568 98.9% 24,944
Slide 8: Consolidated Balance Sheets
Q1 of FY03/2025 results ■ Consolidated Balance Sheets FY03/2024 Q1 of FY03/2025 (Millions of JPY) (Millions of JPY) Current assets 242,745 Current 170,647 Current assets Current 180,266 liabilities 253,114 liabilities 76.6% 53.8% 77.5% 55.2% Long-term 36,609 liabilities 11.6% Long-term 35,834 liabil
Slide 9: Forecasts for FY03/2025
Q1 of FY03/2025 results ■ Forecasts for FY03/2025 Q1 of FY03/2025 Q2 of FY03/2025 Year-end (Millions of JPY) Progress(%) Progress(%) Results forecast forecast Net sales 245,604 488,000 50.3 969,000 25.3 Operating income 4,710 8,650 54.5 16,300 28.9 Ordinary income 5,057 8,750 57.8 16,600 30.5 Profit
Slide 10: Topics
Q1 of FY03/2025 results Topics 10
Slide 11: Building a Logistics Infrastructure to Support Growth: Development of New Logistics Centers
Q1 of FY03/2025 results ■ Building a Logistics Infrastructure to Support Growth: Development of New Logistics Centers Strengthen logistics system to respond to growth strategies in Long-Term Management Vision 2030 Land acquisition at the new Hokkaido Center Location: Okadama Cho, Higashi-ku, Sapporo
Slide 12: Cautionary Statement with Respect to Forward-Looking Statements
Cautionary Statement with Respect to Forward-Looking Statements ⚫ This material is solely for information purposes and should not be construed as a solicitation. This document (including the performance plan) has been prepared by us based on reliable information currently available, but it involves